Proficio Capital Partners LLC Biogen Inc. Transaction History

Proficio Capital Partners LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 19, 2023	BUY	$256.56 - $292.34 $15.2 Million - $17.3 Million	59,220 New	59,220 $16.5 Million
Q4 2019 Feb 13, 2020	SELL	$220.06 - $304.07 $1.17 Million - $1.62 Million	-5,325 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $22,806 - $25,138	-104 Reduced 1.92%	5,325 $1.25 Million
Q1 2019 May 13, 2019	BUY	$216.71 - $338.96 $47,676 - $74,571	220 Added 4.22%	5,429 $1.28 Million
Q4 2018 Feb 08, 2019	SELL	$278.5 - $352.75 $1,114 - $1,411	-4 Reduced 0.08%	5,209 $1.57 Million
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $880 - $1,151	3 Added 0.06%	5,213 $1.84 Million
Q2 2018 Aug 10, 2018	BUY	$257.52 - $306.91 $1,802 - $2,148	7 Added 0.13%	5,210 $1.51 Million
Q1 2018 May 14, 2018	SELL	$260.13 - $367.91 $5,722 - $8,094	-22 Reduced 0.42%	5,203 $1.43 Million
Q4 2017 Feb 09, 2018	BUY	$307.64 - $344.58 $309,485 - $346,647	1,006 Added 23.84%	5,225 $1.67 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $1.19 Million - $1.39 Million	4,219	4,219 $1.32 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Proficio Capital Partners LLC with notifications on news.